The Effect of 6 and 12 months Duodenal-Jejunal Bypass Liner Treatment on Obesity and Type 2 Diabetes: a Crossover Cohort Study

被引：0
|
作者：
Selwyn van Rijn
Bark Betzel
Charlotte de Jonge
David P. J. van Dijk
Ignace M. Janssen
Frits J. Berends
Nicole D. Bouvy
Jan Willem M. Greve
机构：
[1] Maastricht University Medical Center,Department of General Surgery
[2] Rijnstate Medical Center,Department of General Surgery
[3] Zuyderland Medical Center,Department of General Surgery
来源：
Obesity Surgery | 2018年 / 28卷
关键词：
Obesity; Abdominal surgery; Duodenal-jejunal bypass liner; Type 2 diabetes mellitus;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1255 / 1262
页数：7
相关论文
共 50 条
  • [31] The Duodenal-Jejunal Bypass Sleeve (EndoBarrier Gastrointestinal Liner) for Weight Loss and Treatment of Type II Diabetes
    Shaneel R. Patel
    John Mason
    Nadey Hakim
    Indian Journal of Surgery, 2012, 74 : 275 - 277
  • [32] Initial human experience with restrictive duodenal-jejunal bypass liner for treatment of morbid obesity
    Escalona, Alex
    Yanez, Ricardo
    Pimentel, Fernando
    Galvao, Manoel
    Ramos, Almino Cardoso
    Turiel, Dannae
    Boza, Camilo
    Awruch, Diego
    Gersin, Keith
    Ibanez, Luis
    SURGERY FOR OBESITY AND RELATED DISEASES, 2010, 6 (02) : 126 - 131
  • [33] Duodenal-jejunal lap bypass to treat type 2 diabetes in grade I obesity
    Ramos, Almino Cardoso
    Galvao Neto, Manoel
    Rubino, Francesco
    Galvao, Manoela
    Carlo, Andrey
    OBESITY SURGERY, 2007, 17 (08) : 1065 - 1066
  • [34] The Duodenal-Jejunal Bypass Sleeve (EndoBarrier Gastrointestinal Liner) for Weight Loss and Treatment of Type II Diabetes
    Patel, Shaneel R.
    Mason, John
    Hakim, Nadey
    INDIAN JOURNAL OF SURGERY, 2012, 74 (04) : 275 - 277
  • [35] Duodenal jejunal bypass liner treatment for type 2 diabetes and obesity: comparison between 9 and 12 months implantation using data from a worldwide registry
    Ryder, R. E. J.
    Lopez-Gonzalez, R.
    Lazzara, C.
    Gebelli, J. P.
    Munro, L.
    Frydenberg, H.
    Stein, J.
    Battelino, T.
    Fishman, S.
    Byrne, J.
    de Jonge, C.
    Greve, J. -W.
    Cohen, R.
    Yadagiri, M.
    Sen Gupta, P.
    DIABETOLOGIA, 2024, 67 : S379 - S379
  • [36] WHAT HAPPENS TO OVERWEIGHT AND TYPE 2 DIABETES AFTER EXPLANTATION OF THE ENDOBARRIER/DUODENAL-JEJUNAL BYPASS LINER?
    Betzel, B.
    Koehestanie, P.
    Aarts, E.
    Homan, J.
    Dogan, K.
    Wahab, P.
    Groenen, M.
    Janssen, I.
    Berends, F.
    OBESITY SURGERY, 2014, 24 (08) : 1309 - 1309
  • [37] EFFICACY AND SAFETY OF THE DUODENAL-JEJUNAL BYPASS LINER: A PROSPECTIVE COHORT STUDY OF 200 PATIENTS
    Betzel, Bark
    Homan, Jens
    Schijns, Wendy
    Deden, Laura
    van Rens, Michiel
    Aarts, Edo
    Janssen, Ignace
    Wahab, Peter
    Groenen, Marcel
    Berends, Frits
    OBESITY SURGERY, 2015, 25 : S55 - S55
  • [38] Implantation of an endoscopically deployed duodenal-jejunal bypass Liner (DJBL) in obese type 2 diabetes subjects-12 months follow up of eight subjects
    Stratmann, B.
    Krepak, Y.
    Hauber, M.
    Lee-Barkey, Y. H.
    Fischer, M.
    Diethelm, T.
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2014, 122 (03)
  • [39] DUODENAL-JEJUNAL BYPASS LINER FOR TREATMENT OF TYPE 2 DIABETES AND OBESITY: FOUR YEAR OUTCOMES IN THE FIRST NATIONAL HEALTH SERVICE (NHS) ENDOBARRIER SERVICE
    Ryder, R.
    Yadagiri, M.
    Burbridge, W.
    Irwin, S.
    Gandhi, H.
    Bashir, T.
    Allden, R.
    Wyres, M.
    Cull, M.
    Bleasdale, J.
    Fogden, E.
    Anderson, M.
    Sen Gupta, P.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2022, 24 : A191 - A192
  • [40] Comment on: Initial human experience with restrictive duodenal-jejunal bypass liner for treatment of morbid obesity
    Brethauer, Stacy A.
    SURGERY FOR OBESITY AND RELATED DISEASES, 2010, 6 (02) : 131 - 131
12345